Angelini Ventures - aVenture Asset Manager Research
Angelini Ventures
Operating Status: Operating
Angelini Ventures, a €300M venture capital fund, invests in early-stage biotech, digital health, and life sciences startups globally.
Location
Rome, Province of Rome, IT
Founded
2021
Angelini Ventures, the venture capital arm of Angelini Industries, invests globally in early-stage biotech, digital health, and life sciences companies. With a €300 million fund, they focus on innovative solutions in brain health and consumer segments targeting women, children, and the elderly. Their investments span Europe, North America, and Israel, typically participating in Series A to C rounds.
The firm's portfolio includes notable companies such as Avation Medical, Cadence Neuroscience, and Cour Pharmaceuticals. Angelini Ventures aims to leverage technology to improve healthcare, reshape patient journeys, and address unmet needs in vulnerable populations. They offer comprehensive support to entrepreneurs throughout the company-building process and have established partnerships with top investors worldwide.
Angelini Ventures - Portfolio Snapshot
Portfolio activity breakdown across disclosed investments and stages
